Correlacion entre hemoglobina glicosilada con hallazgos sintax score ii en pacientes con sospecha clínica de enfermedad coronaria, hospitalizados en la unidad coronaria del hospital San José centro en enero a septiembre del año 2015


Autoria(s): Martinez Casas, Omar Yesid; Vargas Vergara, Diana
Contribuinte(s)

Birchenall Jimenez, Claudia Ines

Data(s)

30/09/2016

Resumo

Se realiza un estudio de corte transversal en el periodo de enero a septiembre del año 2016 en la unidad coronaria del Hospital San José Centro de la Ciudad de Bogotá; en pacientes con sospecha de enfermedad coronaria (Síndrome coronario agudo y angina estable) y antecedente de Diabetes Mellitus Tipo 2, se recolectaron 42 pacientes con los criterios de inclusión a quienes se realizó angiografía coronaria como parte del protocolo de estudio y manejo de la unidad, el objetivo primario fue demostrar la posible correlación entre niveles de hemoglobina glicosilada y la escala de severidad SYNTAX Score I y II de enfermedad coronaria, como objetivos secundarios; caracterizar las variables sociodemográficas, comorbilidades y posible relación con el tipo de presentación de enfermedad coronaria. Como hallazgos relevantes no se encontró correlación importante ni significativa entre niveles de hemoglobina glicosilada y la escala Syntax score II ni Syntax score I, a pesar de que la mayoría de pacientes mostraban mal control crónico de su diabetes mellitus tipo 2, con niveles mayores > 7%, como hallazgo positivo se encontro asociación estadísticamente significativa con niveles de LDL y las diferentes formas de presentación de enfermedad coronaria, a mayor niveles de LDL mayor probabilidad de IAM e IAM con elevación del segmento ST. Se considera que con estudios multicentricos en diferentes ciudades y unidades de cuidado cardiovascular con diferentes niveles de riesgo, se podría demostrar la posible correlación entre niveles de hemoglobina glicosilada y los grados de severidad de enfermedad coronaria representados por las escalas Syntax score I y II.

Diana Vargas

We made a cross sectional study in the period from January to September 2016 in the coronary care unit of Hospital San Jose Downtown Bogota; in patients with suspected coronary artery disease (acute coronary syndrome and stable angina) and a history of Diabetes Mellitus Type 2, 42 patients were collected with the inclusion criteria whom coronary angiography was performed as part of the study protocol and management of the unit, the primary objective was to demonstrate the possible correlation between glycated hemoglobin levels and the severity scale SYNTAX Score I and II of coronary disease, as secondary objectives; characterize the sociodemographic variables, comorbidities and possible relationship to the type of presentation of coronary disease. As important findings not important or significant correlation was found between glycated hemoglobin levels and scale SYNTAX Score II or Syntax score I, although most patients had chronic bad control of their diabetes mellitus type 2, with higher levels> 7 % as a positive finding statistically significant association with LDL levels and different ways of presenting coronary disease was found, the higher the levels of LDL higher probability of AMI and AMI with ST segment elevation. It is considered that with multicenter studies in different cities and cardiovascular care units with different levels of risk, could demonstrate the possible correlation between glycated hemoglobin levels and degrees of severity of coronary disease represented by the scales Syntax score I and II

Formato

application/pdf

Identificador

http://repository.urosario.edu.co/handle/10336/12655

Idioma(s)

spa

Publicador

Facultad de medicina

Direitos

info:eu-repo/semantics/openAccess

Fonte

instname:Universidad del Rosario

reponame:Repositorio Institucional EdocUR

1. Christian W. Hamm, Bassand Jean-pierre, Stefan Agewall, Bax Jeroen, Eric Boersma HB, Italia PC, Polonia DD, Gielen S, Ohman M, Unidos E, et al. Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST Grupo de Trabajo para el manejo del síndrome coronario agudo ( SCA ) en pacientes sin elevación. Rev Española Cardiol. 2014;65(2):1–55

2. Muñoz González J, Viñedo Campillo L, Guerrero Sanz J. Síndrome coronario agudo sin elevación del ST: angina inestable e infarto de miocardio sin elevación del segmento ST. 2007;9(89):5736-5744.

3. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Inter Heart study. 2004;937–52.

4. Karakoyun S, Gokdeniz T, Gursoy MO, Rencuzo ullar I, Karaba Y, Alt nta B, et al. Increased Glycated Hemoglobin Level is Associated With SYNTAX Score II in Patients With Type 2 Diabetes Mellitus. Angiology [Internet]. 2015;1–7. Available from: http://ang.sagepub.com/cgi/doi/10.1177/0003319715591752

5. Bahn GD, Ph D, Reda DJ, Ph D, Ge L, Mccarren M, et al. Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes. 2015;2197–206.

6. Zamorano J, Achenbach S, Baumgartner H, Jeroen J, Bueno H, et al. Guía de práctica clínica de la ESC sobre revascularización miocárdica, 2014. Revista Española de Cardiología. 2015;68(2):144.e1-144.e95.

7. González-Maqueda I. La enfermedad coronaria del diabético. Diagnóstico, pronóstico y tratamiento. Rev Esp Cardiol Supl. 2007;7(H):29–41.

8. Carmena R. Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance. Am Heart J 2005; 150: 859-70.

9. Schinner S. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. Yearb Med. 2009;2009:525–7.

10. Cholesterol Treatment Trialists (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: a metaanalysis. Lancet 2008; 371: 117-25.

11. Grundy SM, Cleeman JL, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute. Scientific Statement. Circulation. 2005.

12. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28: 1.769-1.778

13. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000;102(9):1014–9.

14. Diabetes Control and Complications Trial Research Group (DCCT). The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent Diabetes Mellitus: the Diabetes Control and Complications Trial. N Eng J Med 1993; 329, 978-86.

15. Holman RR, Paul SK, Bethel AM, Matthews DR, Neil HA. 10 years follow-up of intensive glucose control in type 2 Diabetes. N Eng J Med 2008; 359: 1577-89.

16. King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999;48(5):643–8.

17. Wills B a, Dung NM, Loan HT, Tam DTH, Thuy TTN, Minh LTT, et al. New England Journal. World Health. 2005;877–89.

18. Mohr FW, Rastan AJ, Serruys PW, Kappetein a. P, Holmes DR, Pomar JL, et al. Complex coronary anatomy in coronary artery bypass graft surgery: Impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg [Internet]. The American Association for Thoracic Surgery; 2011;141(1):130–40. Available from: http://dx.doi.org/10.1016/j.jtcvs.2010.07.094

19. Serruys, PW, Onuma, Y, Garg, S et al. Assessment of the SYNTAX score in the Syntax study.EuroIntervention. 2009; 5: 50–56

20. Levine, GN, Bates, ER, Blankenship, JC et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011; 58: e44–122

21. Vasim Farooq, David van Klaveren, Ewout W Steyerberg, Emanuele Meliga, Yvonne Vergouwe, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013; 381: 639–50.

22. Xu B, Généreux P, Yang Y, Leon MB, Xu L, Qiao S, Wu Y, Yan H, Chen J, Zhao Y, Zhao Y, Palmerini T, Stone GW,Gao R, et al. Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention. JACC Cardiovasc Interv. 2014 Oct;7(10):1128-37.

23. Emerging T, Factors R. Diabetes mellitus , fasting blood glucose concentration , and risk of vascular disease : a collaborative meta-analysis of 102 prospective studies. Lancet [Internet]. Elsevier Ltd; 2010;375(9733):2215–22. Available from: http://dx.doi.org/10.1016/S0140-6736(10)60484-9

24. Karakoyun S, Gökdeniz T, Gürsoy MO, Rencüzoʇullarl I, Karabaʇ Y, Altlntaş B, et al. Increased glycated hemoglobin level is associated with SYNTAX score II in patients with type 2 diabetes mellitus. Angiology [Internet]. 2016;67(4):384–90.

25. Arbel Y, Zlotnik M, Halkin A, Havakuk O, Berliner S, Herz I, et al. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography. Clin Res Cardiol. 2014;103(3):223–7.

26. Farooq V, Van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: Development and validation of SYNTAX score II. Lancet. 2013;381(9867):639–50.

27. Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A, et al. Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome. J Am Coll Cardiol [Internet]. Elsevier Inc.; 2010;55(21):2399–407.

Palavras-Chave #Epidemiología #614.4 #Epidemiología #Enfermedad coronaria #Diabetes mellitus #Enfermedades cardiovasculares #Syntax score I #Syntax score II #acute coronary syndrome #glycosylated hemoglobin
Tipo

info:eu-repo/semantics/bachelorThesis

info:eu-repo/semantics/acceptedVersion